Available Q5134 Injection, natalizumab-sztn
(tyruko), biosimilar, 1 mg
Learn More NDC Code2
61314-0543-94

References:
1. Healthcare Common Procedure Coding System (HCPCS) Application Summaries and Coding Recommendations: Fourth Quarter, 2023 HCPCS Coding Cycle. Centers for Medicare & Medicaid Services. Accessed August 22, 2024.

https://www.cms.gov/files/document/2023-hcpcs-application-summary-quarter-4-2023-drugs-and-biologicals-updated-04/25/2024.pdf

2. Tyruko. Prescribing information. Sandoz Inc. Accessed December 1, 2025.

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ef653c36-dd4b-4e71-9d2d-40b8fea24b67

© 2026 Sandoz Inc
100 College Road West, Princeton, NJ 08540
MLR-2103-US    08/2026

Please see full Prescribing Information,
Including Boxed Warning.